Disclosures for "Hemorrhagic Cerebral Venous Thrombosis (CVT) - Risk Factors, Outcome, and Prevalence of Novel Biomarkers (Antiphospholipid Antibodies & IgG Antibodies to Spike Protein of SARSCoV2)"